Advarra Acquires IntegReview IRB

Advarra is pleased to announce the acquisition of IntegReview IRB. The addition of IntegReview enables Advarra to continue its expansion of comprehensive review solutions capabilities in North America.

“IntegReview and Advarra share a mission-driven passion for protecting clinical trial participants,” said Gadi Saarony, CEO of Advarra. “Our aim is to benefit clinical trials and drug development through expanded subject matter expertise, technology-enabled efficiencies, and continuing commitment to ethics, quality, and service. We are excited to welcome more talent to enhance our combined capabilities and geographic footprint.”

The Austin, Tex. headquarters for IntegReview will become the first Advarra office in the southern US. The acquisition also increases depth of expertise in many key areas, most notably in early phase research.

“We are excited to be a part of the Advarra family” said Lynn Meyer, founder and Managing Partner of IntegReview. “We were attracted to Advarra’s extensive regulatory depth and their model of integrated IRB operations and focus on building client relationships and deep collaboration with the site community.”

For more information, click here.​